Skip to main content
Premium Trial:

Request an Annual Quote

Waters Sells $100M in Senior Notes Offering; Plans Another $100M Offering

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters has sold $100 million worth of 3.75 percent Series A Senior Notes due Feb. 1, 2015, in a private placement with institutional purchasers, the firm said in a filing with the US Securities and Exchange Commission today.

The placement was made yesterday and is the first of two senior notes offerings. In the second, expected to take place on March 1, 2010, Waters intends to sell $100 million worth of 5 percent Series B Senior Notes due Feb. 1, 2020.

Interest on the notes is payable semi-annually on Feb. 1 and Aug. 1 each year.

Waters said that it will use the proceeds from the two private placements to repay other outstanding debt and for general corporate purposes.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.